{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:50:04Z","timestamp":1791658204336,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.taap.2026.118069","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:34:05Z","timestamp":1791243245000},"page":"118069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["METTL3-mediated m6A modification of PARP2 accelerates hepatocellular carcinoma progression"],"prefix":"10.1016","volume":"517","author":[{"given":"Mengke","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2026.118069_bb0005","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cmet.2012.06.016","article-title":"The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease","volume":"16","author":"Bai","year":"2012","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.taap.2026.118069_bb0010","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000932","article-title":"The global epidemiology of hepatocellular carcinoma","volume":"10","author":"Butt","year":"2026","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.taap.2026.118069_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40364-021-00278-9","article-title":"Novel insights into the m6A-RNA methyltransferase METTL3 in cancer","volume":"9","author":"Cai","year":"2021","journal-title":"Biomark. Res."},{"key":"10.1016\/j.taap.2026.118069_bb0020","first-page":"9924","article-title":"CircRNA ZFR stimulates the proliferation of hepatocellular carcinoma through upregulating MAP2K1","volume":"24","author":"Cedric","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.taap.2026.118069_bb0025","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/hep.29683","article-title":"RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2","volume":"67","author":"Chen","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2026.118069_bb0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12943-019-1033-z","article-title":"The role of m6A RNA methylation in human cancer","volume":"18","author":"Chen","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.taap.2026.118069_bb0035","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41419-017-0129-x","article-title":"N6-methyladenosine links RNA metabolism to cancer progression","volume":"9","author":"Dai","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2026.118069_bb0040","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41422-018-0034-6","article-title":"RNA N6-methyladenosine modification in cancers: current status and perspectives","volume":"28","author":"Deng","year":"2018","journal-title":"Cell Res."},{"issue":"10","key":"10.1016\/j.taap.2026.118069_bb0045","first-page":"745","article-title":"METTL3-mediated m6A modification of FMRP drives hepatocellular carcinoma progression and indicates poor prognosis","volume":"39","author":"Fu","year":"2024","journal-title":"Cancer Biother. Radiopharm."},{"issue":"1","key":"10.1016\/j.taap.2026.118069_bb0050","article-title":"Development of a four-gene prognostic signature for hepatocellular carcinoma using TCGA and GEO datasets","volume":"17","author":"Gu","year":"2026","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.taap.2026.118069_bb0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/0113892029308243240709073945","article-title":"Integrative bioinformatics analysis for targeting hub genes in hepatocellular carcinoma treatment","volume":"26","author":"Gudivada","year":"2025","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.taap.2026.118069_bb0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.semdp.2016.12.011","article-title":"The diagnosis and treatment of hepatocellular carcinoma","volume":"34","author":"Hartke","year":"2017","journal-title":"Semin. Diagn. Pathol."},{"issue":"3","key":"10.1016\/j.taap.2026.118069_bb0065","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41418-024-01406-2","article-title":"METTL3 confers oxaliplatin resistance through the activation of G6PD-enhanced pentose phosphate pathway in hepatocellular carcinoma","volume":"32","author":"Jin","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.taap.2026.118069_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2017.0112","article-title":"Epidemiology of liver cancer in South Korea","volume":"24","author":"Kim","year":"2018","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.taap.2026.118069_bb0075","doi-asserted-by":"crossref","first-page":"eadf7175","DOI":"10.1126\/sciadv.adf7175","article-title":"Clinical PARP inhibitors allosterically induce PARP2 retention on DNA","volume":"9","author":"Langelier","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.taap.2026.118069_bb0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.taap.2026.118069_bb0085","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41556-018-0174-4","article-title":"m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer","volume":"20","author":"Liu","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.taap.2026.118069_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2018.00089","article-title":"Link between m6A modification and cancers","volume":"6","author":"Liu","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.taap.2026.118069_bb0095","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10565-025-10039-1","article-title":"METTL3-mediated m6A methylation in cardiac diseases: pathogenic roles and therapeutic potential","volume":"41","author":"Liu","year":"2025","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.taap.2026.118069_bb0100","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41419-021-03585-z","article-title":"Emerging role of RNA modification N6-methyladenosine in immune evasion","volume":"12","author":"Lou","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2026.118069_bb0105","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1111\/febs.16142","article-title":"ADP-ribosyltransferases, an update on function and nomenclature","volume":"289","author":"Luscher","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.taap.2026.118069_bb0110","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1001\/jamaoncol.2023.7322","article-title":"PARP inhibitors for breast cancer treatment: a review","volume":"10","author":"Morganti","year":"2024","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.taap.2026.118069_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114321","article-title":"Selective degradation of PARP2 by PROTACs via recruiting DCAF16 for triple-negative breast cancer","volume":"236","author":"Pu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.taap.2026.118069_bb0120","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ijrobp.2020.07.033","article-title":"A pilot trial evaluating stereotactic body radiation therapy to induce hyperemia in combination with transarterial chemoembolization for hepatocellular carcinoma","volume":"108","author":"Sebastian","year":"2020","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.taap.2026.118069_bb0125","doi-asserted-by":"crossref","DOI":"10.2174\/0118761429310703240823045808","article-title":"Mechanism, potential, and concerns of immunotherapy for hepatocellular carcinoma and liver transplantation","volume":"17","author":"Sensi","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.taap.2026.118069_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215919","article-title":"PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer","volume":"550","author":"Shen","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.taap.2026.118069_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01126","article-title":"Reduced expression of METTL3 promotes metastasis of triple-negative breast cancer by m6A methylation-mediated COL3A1 up-regulation","volume":"10","author":"Shi","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.taap.2026.118069_bb0140","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1101\/gad.334516.119","article-title":"PARP and PARG inhibitors in cancer treatment","volume":"34","author":"Slade","year":"2020","journal-title":"Genes Dev."},{"key":"10.1016\/j.taap.2026.118069_bb0145","doi-asserted-by":"crossref","first-page":"9559","DOI":"10.1002\/cam4.5732","article-title":"Five-year survival post hepatectomy for colorectal liver metastases in a real-world Chinese cohort: recurrence patterns and prediction for potential cure","volume":"12","author":"Su","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.taap.2026.118069_bb0150","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.7150\/ijbs.70458","article-title":"The role of insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) as m6A readers in cancer","volume":"18","author":"Sun","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.taap.2026.118069_bb0155","first-page":"621","article-title":"The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells","volume":"52","author":"Taketo","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.taap.2026.118069_bb0160","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.taap.2026.118069_bb0165","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1111\/j.1742-4658.2011.08286.x","article-title":"Identification of candidate substrates for poly(ADP-ribose) polymerase-2 (PARP2) in the absence of DNA damage using high-density protein microarrays","volume":"278","author":"Troiani","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.taap.2026.118069_bb0170","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.4416","article-title":"The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.taap.2026.118069_bb0175","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N6-methyladenosine modulates messenger RNA translation efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.taap.2026.118069_bb0180","first-page":"7903","article-title":"Metronomic chemotherapy remodel cancer-associated fibroblasts to decrease chemoresistance of gastric cancer in nude mice","volume":"14","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.taap.2026.118069_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.137","article-title":"Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: a single-center, retrospective, propensity-matched study","volume":"10","author":"Wang","year":"2020","journal-title":"Clin. Transl. Med."},{"issue":"7","key":"10.1016\/j.taap.2026.118069_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112704","article-title":"Loss of Mettl3 enhances liver tumorigenesis by inducing hepatocyte dedifferentiation and hyperproliferation","volume":"42","author":"Wei","year":"2023","journal-title":"Cell Rep."},{"issue":"14","key":"10.1016\/j.taap.2026.118069_bb0195","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.7150\/ijbs.120413","article-title":"METTL3-mediated m6A methylation on lncRNA H19 inhibits intrahepatic cholangiocarcinoma progression through PPAR\u03b3 downregulation","volume":"21","author":"Xiao","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.taap.2026.118069_bb0200","article-title":"Dual role of pregnane x receptor in nonalcoholic fatty liver disease","volume":"17","author":"Xu","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.taap.2026.118069_bb0205","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/jcp.30023","article-title":"m6 a transferase METTL3-induced lncRNA ABHD11-AS1 promotes the Warburg effect of non-small-cell lung cancer","volume":"236","author":"Xue","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.taap.2026.118069_bb0210","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.taap.2026.118069_bb0215","first-page":"E2047","article-title":"Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA","volume":"113","author":"Zhang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.taap.2026.118069_bb0220","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1093\/nar\/gkaa347","article-title":"Dynamic landscape and evolution of m6A methylation in human","volume":"48","author":"Zhang","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.taap.2026.118069_bb0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41419-024-07317-x","article-title":"METTL3 inhibition promotes radiosensitivity in hepatocellular carcinoma through regulation of SLC7A11 expression","volume":"16","author":"Zhang","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2026.118069_bb0230","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1186\/s12885-019-5936-2","article-title":"Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma","volume":"19","author":"Zhou","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.taap.2026.118069_bb0235","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41419-022-04817-6","article-title":"METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition","volume":"13","author":"Zhu","year":"2022","journal-title":"Cell Death Dis."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26003650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26003650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:42:18Z","timestamp":1791657738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26003650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":47,"alternative-id":["S0041008X26003650"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.118069","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"METTL3-mediated m6A modification of PARP2 accelerates hepatocellular carcinoma progression","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.118069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118069"}}